|
1
|
Liu Y, Chen S, Zühlke L, Black GC, Choy
MK, Li N and Keavney BD: Global birth prevalence of congenital
heart defects 1970-2017: Updated systematic review and
meta-analysis of 260 studies. Int J Epidemiol. 48:455–463.
2019.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Li L, Jick S, Breitenstein S, Hernandez G,
Michel A and Vizcaya D: Pulmonary arterial hypertension in the USA:
An epidemiological study in a large insured pediatric population.
Pulm Circ. 7:126–136. 2017.PubMed/NCBI View
Article : Google Scholar
|
|
3
|
Rubin LJ: Primary pulmonary hypertension.
N Engl J Med. 336:111–117. 1997.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Huang F, Wong X and Jan LY: International
Union of Basic and Clinical Pharmacology. LXXXV: Calcium-activated
chloride channels. Pharmacol Rev. 64:1–15. 2012.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Hübner CA, Schroeder BC and Ehmke H:
Regulation of vascular tone and arterial blood pressure: Role of
chloride transport in vascular smooth muscle. Pflugers Arch.
467:605–614. 2015.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Yang Z, Zhang Z, Xu Y, Li Y and Ye T:
Relationship of intracellular free Ca2+ concentration
and calcium-activated chloride channels of pulmonary artery smooth
muscle cells in rats under hypoxic conditions. J Huazhong Univ Sci
Technolog Med Sci. 26:172–174, 191. 2006.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Zaiman AL, Damico R, Thoms-Chesley A,
Files DC, Kesari P, Johnston L, Swaim M, Mozammel S, Myers AC,
Halushka M, et al: A critical role for the protein apoptosis
repressor with caspase recruitment domain in hypoxia-induced
pulmonary hypertension. Circulation. 124:2533–2542. 2011.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Caputo A, Caci E, Ferrera L, Pedemonte N,
Barsanti C, Sondo E, Pfeffer U, Ravazzolo R, Zegarra-Moran O and
Galietta LJ: TMEM16A, a membrane protein associated with
calcium-dependent chloride channel activity. Science. 322:590–594.
2008.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Schroeder BC, Cheng T, Jan YN and Jan LY:
Expression cloning of TMEM16A as a calcium-activated chloride
channel subunit. Cell. 134:1019–1029. 2008.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Yang YD, Cho H, Koo JY, Tak MH, Cho Y,
Shim WS, Park SP, Lee J, Lee B, Kim BM, et al: TMEM16A confers
receptor-activated calcium-dependent chloride conductance. Nature.
455:1210–1215. 2008.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Tian XQ, Ma KT, Wang XW, Wang Y, Guo ZK
and Si JQ: Effects of the calcium-activated chloride channel
inhibitors T16Ainh-A01 and CaCCinh-A01 on cardiac fibroblast
function. Cell Physiol Biochem. 49:706–716. 2018.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Hyuga S, Danielsson J, Vink J, Fu XW,
Wapner R and Gallos G: Functional comparison of anoctamin 1
antagonists on human uterine smooth muscle contractility and
excitability. J Smooth Muscle Res. 54:28–42. 2018.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Martinez-Pinna J, Soriano S, Tuduri E,
Nadal A and de Castro F: A calcium-dependent chloride current
increases repetitive firing in mouse sympathetic neurons. Front
Physiol. 9(508)2018.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Revermann M, Schloss M, Mieth A, Babelova
A, Schröder K, Neofitidou S, Buerkl J, Kirschning T, Schermuly RT,
Hofstetter C and Brandes RP: Levosimendan attenuates pulmonary
vascular remodeling. Intensive Care Med. 37:1368–1377.
2011.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Sun H, Xia Y, Paudel O, Yang XR and Sham
JS: Chronic hypoxia-induced upregulation of Ca2+-activated Cl-
channel in pulmonary arterial myocytes: A mechanism contributing to
enhanced vasoreactivity. J Physiol. 590:3507–3521. 2012.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Wang K, Ma J, Pang Y, Lao J, Pan X, Tang
Q, Zhang F, Su D, Qin S and Shrestha AP: Niflumic acid attenuated
pulmonary artery tone and vascular structural remodeling of
pulmonary arterial hypertension induced by high pulmonary blood
flow in vivo. J Cardiovasc Pharmacol. 66:383–391. 2015.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Lao J, Pang Y, Wang K, Liu D, Su D, Zhang
F, Pan X and Li S: Inhibition of survivin promotes pulmonary
arterial smooth muscle cell apoptosis in high blood flow-induced
pulmonary arterial hypertension in rats. Int J Clin Exp Pathol.
9:6821–6834. 2016.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Wang K, Chen C, Ma J, Lao J and Pang Y:
Contribution of calcium-activated chloride channel to elevated
pulmonary artery pressure in pulmonary arterial hypertension
induced by high pulmonary blood flow. Int J Clin Exp Pathol.
8:146–154. 2015.PubMed/NCBI
|
|
19
|
Manoury B, Tamuleviciute A and Tammaro P:
TMEM16A/anoctamin 1 protein mediates calcium-activated chloride
currents in pulmonary arterial smooth muscle cells. J Physiol.
588:2305–2314. 2010.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Wang B, Li C, Huai R and Qu Z:
Overexpression of ANO1/TMEM16A, an arterial
Ca2+-activated Cl- channel, contributes to spontaneous
hypertension. J Mol Cell Cardiol. 82:22–32. 2015.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Wang M, Yang H, Zheng LY, Zhang Z, Tang
YB, Wang GL, Du YH, Lv XF, Liu J, Zhou JG and Guan YY:
Downregulation of TMEM16A calcium-activated chloride channel
contributes to cerebrovascular remodeling during hypertension by
promoting basilar smooth muscle cell proliferation. Circulation.
125:697–707. 2012.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Zeng X, Huang P, Chen M, Liu S, Wu N, Wang
F and Zhang J: TMEM16A regulates portal vein smooth muscle cell
proliferation in portal hypertension. Exp Ther Med. 15:1062–1068.
2018.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Dai WJ, Qiu J, Sun J, Ma CL, Huang N,
Jiang Y, Zeng J, Ren BC, Li WC and Li YH: Downregulation of
microRNA-9 reduces inflammatory response and fibroblast
proliferation in mice with idiopathic pulmonary fibrosis through
the ANO1-mediated TGF-β-Smad3 pathway. J Cell Physiol.
234:2552–2565. 2019.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Wu H, Wang H, Guan S, Zhang J, Chen Q,
Wang X, Ma K, Zhao P, Zhao H, Yao W, et al: Cell-specific
regulation of proliferation by Ano1/TMEM16A in breast cancer with
different ER, PR, and HER2 status. Oncotarget. 8:84996–85013.
2017.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Zhang XH, Zheng B, Yang Z, He M, Yue LY,
Zhang RN, Zhang M, Zhang W, Zhang X and Wen JK: TMEM16A and
myocardin form a positive feedback loop that is disrupted by KLF5
during Ang II-induced vascular remodeling. Hypertension.
66:412–421. 2015.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Forrest AS, Joyce TC, Huebner ML, Ayon RJ,
Wiwchar M, Joyce J, Freitas N, Davis AJ, Ye L, Duan DD, et al:
Increased TMEM16A-encoded calcium-activated chloride channel
activity is associated with pulmonary hypertension. Am J Physiol
Cell Physiol. 303:C1229–C1243. 2012.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Deng L, Yang J, Chen H, Ma B, Pan K, Su C,
Xu F and Zhang J: Knockdown of TMEM16A suppressed MAPK and
inhibited cell proliferation and migration in hepatocellular
carcinoma. Onco Targets Ther. 9:325–333. 2016.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Liu J, Liu Y, Ren Y, Kang L and Zhang L:
Transmembrane protein with unknown function 16A overexpression
promotes glioma formation through the nuclear factor-κB signaling
pathway. Mol Med Rep. 9:1068–1074. 2014.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Zeng DX, Xu GP, Lei W, Wang R, Wang CG and
Huang JA: Suppression of cyclin D1 by plasmid-based short hairpin
RNA ameliorated experimental pulmonary vascular remodeling.
Microvasc Res. 90:144–149. 2013.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Liu P and Chen L: Inhibition of sonic
hedgehog signaling blocks cell migration and growth but induces
apoptosis via suppression of FOXQ1 in natural killer/T-cell
lymphoma. Leuk Res. 64:1–9. 2018.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Li T, Song T, Ni L, Yang G, Song X, Wu L,
Liu B and Liu C: The p-ERK-p-c-Jun-cyclinD1 pathway is involved in
proliferation of smooth muscle cells after exposure to cigarette
smoke extract. Biochem Biophys Res Commun. 453:316–320.
2014.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Qin L, Yang YB, Yang YX, Gong YZ, Li XL,
Li GY, Luo HD, Xie XJ, Zheng XL and Liao DF: Inhibition of smooth
muscle cell proliferation by ezetimibe via the cyclin D1-MAPK
pathway. J Pharmacol Sci. 125:283–291. 2014.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Duvvuri U, Shiwarski DJ, Xiao D, Bertrand
C, Huang X, Edinger RS, Rock JR, Harfe BD, Henson BJ, Kunzelmann K,
et al: TMEM16A induces MAPK and contributes directly to
tumorigenesis and cancer progression. Cancer Res. 72:3270–3281.
2012.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Song Y, Gao J, Guan L, Chen X, Gao J and
Wang K: Inhibition of ANO1/TMEM16A induces apoptosis in human
prostate carcinoma cells by activating TNF-α signaling. Cell Death
Dis. 9(703)2018.PubMed/NCBI View Article : Google Scholar
|
